DEAN J MITCHELL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DEAN J MITCHELL.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DEAN J MITCHELL. DEAN J MITCHELL is a President, U.S. Primary Care in BRISTOL MYERS SQUIBB CO ($BMY) and a Director in IMMUNOGEN INC ($IMGN) and a Director in INTREXON CORP ($XON) and a Director in Theravance Biopharma, Inc. ($TBPH) and a Director in Kinnate Biopharma Inc. ($KNTE).
Address: BRISTOL-MYERS SQUIBB COMPANY 777 SCUDDERS MILL ROAD PLAINSBORO 08536 NJ
Companies in which DEAN J MITCHELL is an Insider
BRISTOL MYERS SQUIBB CO
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEAN J MITCHELL: President, U.S. Primary Care
Holdings: 60,000 shares
Current Value: $3,099,600
Latest Transaction: Sep 12 2003
$BMY Market Capitalization: $87.00B
$BMY Previous Close: $51.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ImmunoGen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEAN J MITCHELL: Director
Holdings: 10,000 shares
Current Value: $23,800
Latest Transaction: Apr 02 2021
$IMGN Market Capitalization: $205.16M
$IMGN Previous Close: $2.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kinnate Biopharma Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEAN J MITCHELL: Director
Holdings: 0 shares
Latest Transaction: Jun 14 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
PRECIGEN, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEAN J MITCHELL: Director
Holdings: 177,926 shares
Current Value: $3,809,396
Latest Transaction: Mar 29 2021
$XON Market Capitalization: $2.53B
$XON Previous Close: $21.41
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Theravance Biopharma, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DEAN J MITCHELL: Director
Holdings: 51,034 shares
Current Value: $1,561,640
Latest Transaction: Apr 29 2021
$TBPH Market Capitalization: $1.64B
$TBPH Previous Close: $30.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DEAN J MITCHELL
Sentiment: All, BMY, IMGN, KNTE, XON, TBPH
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 14 2021 | KNTE | Kinnate Biopharma ... | MITCHELL DEAN J | Director | Option Exercise | A | 24.46 | 20,250 | 495,315 | 20,250 | |
| Apr 29 2021 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Option Exercise | A | 20.35 | 6,000 | 122,100 | 6,000 | |
| Apr 29 2021 | TBPH | Theravance Biophar ... | MITCHELL DEAN J | Director | Grant | A | 0.00 | 9,828 | 0 | 51,034 | 41.2 K to 51 K (+23.85 %) |
| Apr 02 2021 | IMGN | ImmunoGen, Inc. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 93,774 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 7.71 | 22,107 | 170,445 | 22,107 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Option Exercise | A | 0.00 | 16,212 | 0 | 16,212 | |
| Mar 29 2021 | XON | PRECIGEN, INC. | MITCHELL DEAN J | Director | Grant | A | 7.71 | 7,328 | 56,499 | 177,926 | 170.6 K to 177.9 K (+4.30 %) |